Abeona Therapeutics, Inc. ABEOW 深 滬
等待開盤 07-22 09:30:00 美东时间
0.0698
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0698
- 總市值 2.11亿
- 52周最高 4.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.021
- 委 比 0.00%
- 總股本 30.28亿
- 歷史最高 17.56
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.021
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Abeona Therapeutics Activates Cincinnati Children’s As Seventh Qualified Treatment Center For Administration Of ZEVASKYN To Treat Wounds In Patients With Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the activation of Cincinnati Children’s as the seventh Qualified Treatment Center (QTC) for the administration of ZEVASKYN® (prademagene zami...
07-21 19:37
Abeona Therapeutics grants up to 9,000 restricted shares to five new hires under inducement plan
Abeona Therapeutics grants up to 9,000 restricted shares to five new hires under inducement plan Abeona Therapeutics granted restricted stock awards covering up to 9,000 shares to five new non-executive employees on June 30, 2026. One-third of the restricted shares vest on each annual anniversary of
07-01 19:31
Abeona Therapeutics announces resignation of board member
Abeona Therapeutics ( ($ABEO) ) just unveiled an update. On June 11, 2026, Abeo...
06-12 20:01
Abeona Therapeutics director Michael Amoroso resigns from board, committee roles
Abeona Therapeutics director Michael Amoroso resigns from board, committee roles Abeona Therapeutics reported the resignation of director Michael Amoroso, effective immediately on June 11, 2026. Amoroso also stepped down from the board’s Nominating and Corporate Governance Committee. The departure w
06-12 19:31
Abeona CFO Joseph Vazzano disposes of 49,338 common shares worth $266,815
Abeona CFO Joseph Vazzano disposes of 49,338 common shares worth $266,815 Abeona Therapeutics CFO Joseph Walter Vazzano sold 49,338 common shares on June 8-9, 2026 at weighted-average prices near USD 5.30-5.43. Holdings fell to 518,437 shares following the transactions. Sales included tax-withholdin
06-10 08:33
Abeona Advances ABO-701 T-Cell Therapy Toward IND
Abeona Therapeutics ( ($ABEO) ) has shared an update. On June 3, 2026, Abeona T...
06-04 20:00
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
05-28 18:25
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
Abeona Therapeutics Inc (($ABEO)) has held its Q1 earnings call. Read on for th...
05-20 13:21
Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript
On Wednesday, Abeona Therapeutics (NASDAQ:ABEO) discussed first-quarter financi...
05-13 21:51
Abeona Therapeutics posts smaller-than-expected Q1 loss per share
Abeona Therapeutics posts smaller-than-expected Q1 loss per share Overview US biopharma's Q1 net product revenue rose quarter-over-quarter as ZEVASKYN adoption increased Q1 loss per share beat analyst expectations Co has $168.3M in cash, cash equivalents and short-term investments as of March 31, 20
05-13 19:40
